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Background: Methionine sulfoxide reductase A (MsrA) protects the biological activity of 
proteins from oxidative stress damage and fights onset of age-related hearing loss (Alqudah, ARO 
2015 and 2016). In the current study, we attempted to determine the defect in the protein 
expression of Msrs in adults MsrA knockout mice and the role of MsrA in preventing loss of the 
cellular structures from aging. 
 
 
Method: Mid-modiolar sections from cochlea were incubated overnight at room temperature with 
the primary antibody for MsrA (Abcam, cat# ab16803, diluted 1:100). Next day, the slices were 
incubated with a biotinylated goat anti-rabbit IgG secondary antibody (Vector, cat # BA-1100 
diluted1:400) for 3 h at room temperature, then with a streptavidin Alexa 488 (Thermo Fisher, 
cat# A20000 diluted1:1000) for 1 h. The stained sections were examined under a fluorescence 
microscope. 
For histology analysis, 6-month-old wild-type and MsrA knockout mice were perfused 
intracardially with a fixative solution containing 2.5% glutaraldehyde and 1.5% 
paraformaldehyde. Both inner ears were dissected, postfixed in osmium, embedded in Araldite, 
and sectioned at 20 µm on a microtome. Sections were then mounted on microscope slides and 
spiral ganglion neurons counted. 
Results: Although both mutants and controls showed the same staining intensity of the cochlear 
tissues, there was a clear difference in the immunolabeling of the stained brain sections. This 
observation suggests a relatively low abundance of MsrA protein within the cochlea. 
Semiquantitative analysis of plastic sections of cochlea from 6-month old MsrA knockout mice 
showed loss of cochlear spiral ganglion neurons by 15% in the 16-26 kHz frequencies region, 
iv  
and 60-70% loss of fibrocyte type IV cells when compared to age-matched control mice. 
Conclusion: In this study, we raise the possibility that MsrA represents one component of the 
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Cumulative and irreversible loss of sensory cells (hair cells) and auditory neurons in the 
cochlea, which leads to reductions in threshold sensitivity and speech discrimination, have a 
tremendous negative impact on age-induced hearing loss (AIHL) (Schmiedt, Mills, & Boettcher, 
1996). It is well recognized that the combination of noise exposure and aging can cause the loss 
of additional sensory cells and exacerbate threshold shifts compared with the effects of aging 
alone (Kujawa & Liberman, 2009; Sergeyenko, Kujawa, & Liberman, 2013). The observations 
that noise-damaged ears age differently than undamaged ones (Kujawa & Liberman, 2009), and 
that exposure to noise is more detrimental at younger than at older ages (Kujawa & Liberman, 
2009), suggest that there is a protective and age-related mechanism against damage from 
exposure to noise in the cochlea (Kujawa & Liberman, 2009; Sergeyenko et al., 2013). 
One of the main protagonists in the pathophysiology of aging and noise exposure is 
oxidative stress. In the cochlea, oxidative stress can trigger accumulation of oxidized proteins, 
leading to damage of the sensory cells (hair cells) and auditory neurons, and exacerbate hearing 
loss (Fujimoto & Yamasoba, 2014; Henderson, Bielefeld, Harris, & Hu, 2006). 
Methionine (Met) is an amino acid that is highly susceptible to oxidation, particularly 
under conditions of oxidative stress and aging (Levine & Luo, 2008; Stadtman et al., 2005; 
Stadtman, Moskovitz, & Levine, 2003; Stadtman, 2002). Oxidation of Met to methionine 
sulfoxide (MetO) is reversible, and the reverse reaction is catalyzed by a group of genes called 
methionine sulfoxide reductase system (Msr). This system is subdivided into two different 
subgroups: methionine S-sulfoxide reductase A (MsrA) and methionine R-sulfoxide reductase B 
(MsrB1-3). MsrA reduces both free and protein-based methionine-S-sulfoxide while MsrB is 
special for protein-based methionine-R-sulfoxide The function of the Msr system is to provide 
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necessary protection against oxidative stress by removing the oxygen atoms to repair the 
damaged molecules, which will restore the natural activity of proteins in the cell (Moskovitz, 
2007; Moskovitz et al., 1998; Moskovitz et al., 2001; Salmon et al., 2009). 
Methionine oxidation in proteins of the cochlea is not well understood. To advance this 
field, we will study a biological tool, the MsrA knockout mouse (Oien et al., 2010), which shows 
phenotypes linked with abnormal levels of oxidative stress (Brennan & Kantorow, 2009; Liu et 
al., 2008; Moskovitz et al., 2002; Oien et al., 2010; Oien et al., 2008; Sreekumar, Hinton, & 
Kannan, 2011). More specifically, MsrA mutant mice have shown a phenotypic manifestation 
characterized by progressive neural degeneration (Brennan & Kantorow, 2009; Cabreiro, Picot, 
Friguet, & Petropoulos, 2006; Moskovitz, 2005) and hearing loss (Alqudah, 2016). The 
abolished expression of MsrA gene in mutant MsrA mice will help to determine the hearing 
functions controlled by this gene. It is also a useful tool for looking to the ability of the MsrB 
family of genes to regulate methionine oxidation and their involvement at the onset of hearing 
loss. 
The role of the Msr system, particularly MsrA, in reducing the damage effect of oxidative 
stress in multiple parts of body, has been studied and published by other laboratories (Oien et al., 
2010; Oien et al., 2008; Sreekumar et al., 2011; Moskovitz et al., 2002; Brennan & Kantorow, 
2009; Cabreiro, Picot, Friguet, & Petropoulos, 2006; Moskovitz, 2005; Liu et al., 2008). As 
MsrA assists in preventing formation and accumulation of oxidative stress toxicity in the cells 
(Moskovitz et al., 1998; Novoselov et al., 2010; Oien et al., 2008; Pal, Oien, Ersen, & 
Moskovitz, 2007), production of proteins containing damaged (oxidized) methionine residue 
(MetO) becomes restricted, slowing down the aging process and preventing age-dependent 
neurodegenerative diseases (Moskovitz et al., 1998). Although several investigations reported 
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the presence of oxidative stress markers in the inner ear which are linked to cellular toxicity 
(Fujimoto & Yamabasa, 2014; Henderson, Bielefeld, Harris, & Hu, 2006; Staecker, Qing Yin, & 
Thomas, 2001), the repairing process of damaged proteins, which is a unique feature of the MsrA 
activity, has not been investigated until now due to the lack of a proper animal model. As a 
consequence, studies of the role of the Msr genes in the hearing system have been limited. Using 
MsrA knockout mice to study the effect of all Msr (MsrA and MsrB) genes in protecting the 
cochlea from acoustic overexposure and aging damage is highly innovative and significant. 
Recently, Ahmad et al. (2011) reported that a mutation of the MsrB3 gene causes 
autosomal recessive prelingual human deafness (DFNB74). The mutation also increases 
accumulation of MetO proteins in the cells, causing harm to hearing function from birth. 
Absence of MsrB3 in mice triggers cell loss in the form of apoptotic cell death inside the 
cochlea, degeneration of hair cells stereocilia, and profound hearing impairment by age of 20 
days. These findings suggest an association between mutation of MsrB3 and genetic hearing loss. 
It is important to note, however, that the information regarding the involvement of MsrB3 in age- 
related and noise-induced hearing loss is still missing and needs further investigation. 
Regarding the expression of MsrA gene in the auditory system, a recent study illustrated 
the presence of MsrA in the supporting cells of the organ of Corti and in the spiral ganglion 
neurons (Kwon et al., 2014). MsrA was reported to prevent age-related central nervous system 
(CNS) modifications associated with neurodegenerative diseases (Oien et al., 2008) by 
sustaining proper function of dopaminergic fibers. In the auditory system, these fibers are 
reported to innervate the cochlea arising from the olivocochlear (OC) efferent system in the 
brainstem. Studies have described that dopaminergic fibers project to sensory cells in the inner 
ear to protect hearing function from the damaging effect of acoustic trauma (Gaborjan et 
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al.,1999; Maison et al., 2012). As these dopaminergic neurons are protected by MsrA, it is a good 
candidate to study how Msr genes reduce age-induced hearing loss (AIHL) and the incidence of 
noise-induced hearing loss (NIHL). 
MsrA is highly expressed in the liver and kidney of animals and humans (Moskovitz, 
2007; Moskovitz et al., 2002; Novoselov et al., 2010). In the brain, the MsrA gene is expressed in 
the glial cells and down-regulated during aging (Liu et al., 2008; Pal et al., 2007), which triggers 
the onset of age-related neurodegenerative diseases such as Parkinson’s disease (Liu, et al. 
2008). The latter disorder is pathologically associated with damage and death of dopaminergic 
neurons in the brain (Naoi & Maruyama, 1999; Surmeier, 2010). Ortiz and his colleagues (2011) 
observed that MsrA knockout mice exhibit neurodegenerative brain pathologies and malfunction 
of brain dopaminergic neurons due to the loss of dopamine receptor 2 (D2DR) activity. This 
observation suggests that MsrA knockout mice may have impaired dopaminergic signaling 
pathways also in the cochlea (Maison et al., 2012) and that MsrA might play a pivotal role in 
protecting the auditory dopaminergic neurons from neurodegeneration triggered by aging and 
noise. 
Studies published in the last two decades have shown that the cochlea also contains 
dopaminergic afferent fibers from dopaminergic neurons placed in the cochlear nuclei (Darrow, 
Simons, Dodds, & Liberman, 2006; Gaborjan et al.,1999; Ruel et al., 2001), and that these fibers 
control the cochlear responses evoked by sounds (Maison, 2012). Felix and Ehrenberger (1992) 
provided evidence that the firing rate of afferent fibers in contact with the inner hair cells is 
suppressed following application of dopamine and that dopamine action is mediated by 
dopamine receptor activation. Inoue et al. (2006) demonstrated the expression of several 
dopamine receptors beneath the inner hair cell region, and Darrow et al. (2006) suggested that 
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dopaminergic neurons from the olivocochlear nuclei extend beneath the inner hair cells to form 
dopaminergic endings. However, Maison et al. (2012) recently studied the function of 
dopaminergic fibers in the cochlea using acoustic trauma and showed that mice lacking 
dopamine receptors exhibit exacerbated damage from acoustic trauma, suggesting that 
dopaminergic innervation is most likely essential to reduce the glutamate-induced excitotoxicity, 
neural death causing by increasing the glutamate release after acoustic trauma (Darrow, Simons, 
Dodds, & Liberman, 2006; Gaborjan et al.,1999; Inoue et al., 2006; Liu et al., 2008; Maison et 
al., 2012). Despite the fact that many lines of evidence demonstrate that inner ear dopaminergic 
fibers mediate auditory function, there is no broad indication that suggests these fibers are 
impacted by Parkinson’s disease, an age-related degenerative disorder which induces loss of 
dopaminergic neurons of the brain. 
The importance of understanding the role of MsrA in the hearing system (using the MsrA 
knockout mouse as a model) rests on the possibility that such research might unveil new 
approaches of treating acoustic trauma through Msr-based therapy. Additionally, more 
investigations to determine the specific function of MsrA protection from acoustic trauma and 
aging will provide more clues about a poorly understood phenomenon (i.e., the exacerbation of 
hearing loss in those patients that have both age-related and noise-induced hearing loss). 
Furthermore, using MsrA knockout mice, an animal model widely used to study age-related 
pathologies of the central nervous system (CNS), may provide evidence for the likely 
development of hearing loss in patients suffering from age-related neurodegenerative 
pathologies, such as in Parkinson’s disease. 
For the reasons described above, the preliminary project was designed to define the 
specific involvement of MsrA in protecting against age-related hearing loss, high levels of noise, 
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and the combined effect of these adverse conditions in mice species. We were successful in 
confirming that MsrA defends against oxidative stress generated by aging and noise exposure. 
The related data (see Figure1) showed that, with evaluation of the hearing of old and young, 
wild-type and knockout mice using Audiometry brainstem responses (ABR) and Distortion 
Product Otoacoustic Emissions (DPOAE), mutant animals developed progressive sensorineural 
hearing loss (SNHL) earlier than the controls (starting at 5 weeks versus 16 weeks in wild-type 
mice). This finding suggests that MsrA is involved in protection against age-related hearing loss 
(ARHL). Figure2 illustrates the tendency of the normal and mutant subjects to suffer harmful 
effects from the direct exposure to noise. As seen from this figure, genetic deficiency of MsrA 
causes permanent threshold shift (PTS) up to 30 dB at the frequency region of the noise stimuli, 
compared to 17 dB in controls. While applying a noise stimulus that induces temporary threshold 
shift (TTS) did not noticeably change the hearing ability in wild-type mice, the MsrA knockout 
mice exhibited delay in the recovery of TTS after exposure to loud sound (Alqudah et al., 2015). 
Therefore, we conclude that the protection against noise-induced TTS and PTS are compromised 





Figure 1: Hearing loss is more severe as MsrA knockout mice get older. Baseline ABR and 
DPOAE thresholds in young (5 weeks) and aged (16 weeks) MsrA mutant and wild-type mice. 
Thresholds for groups of animals (MsrA-knock out (-/-) and wild-type (+/+)) at 5 (a, c) and 16 
weeks (b, d) of age are shown for ABRs (top panel) and DPOAEs (lower panel). Both ABR and 
DPOAE thresholds worsened in 16-week-old mice compared to 5-week-old mice. The data are 
expressed as the mean +/- s.e. Each point represents data from 8-11 mice for each group. The key 





Figure 2: MsrA mediates protection to stimuli that generate PTS and TTS damage. Five-week- 
old wild-type mice exposed to a 100 dB SPL noise exposure (2 h at 9-17 kHz) show 18-30 dB 
permanent threshold shifts (PTS) compared to non- exposed mice (p<0.0001 by ANOVA). PTS 
was reduced to 8-17 dB following an application of 97 dB noise level (p<0.05 by ANOVA) and 
exposure to 94 dB noise showed no threshold elevation, suggesting temporary thresholds shift 
(TTS) when compared to the same condition of 4 hrs after the noise (a and c) (p>0.05 by 
ANOVA). In contrast, 5-week-old MsrA knockout mice exposed to the same noise conditions 
show larger threshold shifts (25-40 dB for 100 dB SPL noise and of 19-35 dB for 97 dB SPL). 
TTS-generating stimuli (94 dB SPL) (right panel: b and d) still generated 17-26 dB threshold 
shifts seven days following the noise (gray circle; p<0.0001 by ANOVA). The data are expressed 
as the mean +/- S.E. Each point represents data from 5-11 mice for each group. The key 







Accordingly, in this dissertation project, an anatomical follow-up study is presented and 
discussed to validate the previous electrophysiological findings that indicate MsrA protects 
against neurodegeneration in the cochlea and controls the sensitivity to acoustic trauma. The 
following aims are proposed to investigate and define the biological changes that are caused by 
the loss of MsrA by using two methods: histological tissue analysis and immune-labeling. 
Aim 1: Defining the cellular changes caused by MsrA deficiency by counting the cell 
number for the following structures: spiral ganglion neurons (SG), inner hair cells (IHC), outer 
hair cells (OHC), and fibrocytes. Since the previous data showed loss of hearing and changes in 
gene expression of MsrB1 and MsrB3 in MsrA mutant mice, we assume that the mutation in 
MsrA gene is targeting the main cochlear structures and causes losses in the cell populations 
composed these structures. 
Aim 2: Detecting the defect in protein distribution inside MsrA mutant cochleas by 
staining midmodular sections of wild-type and knockout mice with MsrA antibody that 
recognizes the presence of MsrA antigens in the studied tissues. Our assumption is that MsrA 
protein is expressed in the organ of Corti and the spiral ganglion neurons, which are potential 
sites of the damage generated by MsrA mutation, in older aged populations. Consequently, we 
expect to detect a defect in the MsrA protein distribution inside the mutant cochleas by visually 
recognizing less MsrA localization and intensity staining than in the controls.
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To analyze and report the cochlear histopathology and anatomy in MsrA knockout mice, we have 
designed a breeding colony from a group of mice given by Dr. Moskovitz from the University of 
Kansas. Knockout MsrA mice on a C57BL6/129sv background were backcrossed for more than 
10 generations into a C57BL6 background. All procedures described for this study were 
approved by the Institutional Animal Care and Use Committee (IACUC) of the University of 
Kansas Medical Center (KUMC).  MsrA knockout mice (initially provided by Dr. Moskovitz) 
and wild-type mice (initially obtained from The Jackson Laboratories, Bar Harbor, ME) were 
used to expand our own mouse colony and to generate the presented data. 
During non-experiment times, the animals were maintained in the animal care facility of 
KUMC with all conditions (temperature, moisture and light-dark cycles) set for ideal 
environment and under the supervision of a skilled veterinarian. 
Histology 
 
After the final physiological testing, we conducted the experiment on 6-month-old wild- 
type and MsrA knockout mice. The selected age is the time point when we ensured that the 
phenotype of hearing loss is expressed very strongly in the MsrA knockout mice. The mice were 
deeply anesthetized and perfused intracardially with a fixative solution containing 2.5% 
glutaraldehyde and 1.5% paraformaldehyde in phosphate buffered saline (PBS) for 10 min. Both 
inner ears were dissected out, and the round and oval windows were opened to allow intra- 
labyrinthine perfusion of the same fixative. After overnight post-fixation in the same fixative at 
4°C, the inner ears were osmicated (1% OsO4  in deionized H2O) for 1 h and then decalcified in 
0.1 M EDTA (in PBSA) for two days.  Inner ears were then dehydrated in ethanol and propylene 
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oxide, embedded in araldite, and sectioned at 20 µm on a microtome with a steel knife. Sections 
were then mounted on microscope slides, cover slipped, and observed under a bright-field 
microscope (Nikon, Eclipse 80i). 
Cell counting 
 
The spiral ganglion neurons, hair cells, and fibrocytes were counted in serial sections, 
beginning from section number 29 to 46. Our preliminary data of frequency mapping shows that 
these sections cover the high frequency end of the cochlea. The main reason for selecting that 
area of the cochlear partition is because we found the worst hearing thresholds caused by MsrA 
mutation there. For each subject, all 20 sections were examined under an electron microscope 
(Nikon, Eclipse 80i) using a magnification lens (20X). By focusing the vision throughout the 
entire section thickness, we were able to specify the location of the cell nuclei. Localizing the 
nuclei is essential to make precise determinations of fractional loss for each cell type. 
Furthermore, accuracy was assured by marking the xy position of each nucleus while repeatedly 





Several studies have shown that oxidative stress is one of the possible causes of cell 
death, as it targets the microelements of the cellular structures, such as proteins (Brennan & 
Kantorow, 2009; Moskovitz, 2005; Pal et al., 2007; Moskovitz, 2007). Thus we first evaluated 
the distribution of the MsrA antigens in the intact cochlear tissue, and then, compared the protein 
expressions of normal and MsrA mutant mice. This study comprised three major steps as 
described below. 
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a) Processing the tissue 
 
Animals were sacrificed and the inner ears were isolated and fixed with 4% 
paraformaldehyde in PBS for 1 day at 4°C. The specimens were decalcified using 0.1 M EDTA 
(in PBS) for two days at 4°C. The specimens were then dehydrated using a graded series of 
ethanol solution, cleared in xylene, and embedded in paraffin. Next, the cochleas were placed 
into a plastic mold and left for 1 h in a 60oC oven, oriented with their brain side facing the 
bottom of the mold, and then left to cool slowly overnight. 
b) Sectioning the paraffin blocks 
 
We prepared the paraffin blocks by trimming the excess paraffin around the tissue. The 
blocks were fixed firmly on a plastic holder by melting the edges of paraffin blocks using heated 
metal chuck. We cut the tissue to 12 µm thick sections and gently dropped them in heated water 
bath containing 2 liters of H2O at 39-41˚C. 
c) Immunostaining 
 
Mid-modiolar cochlear sections were cut (12 µm thickness) and placed on a warm plate 
overnight at 39-40˚C. were dewaxed in xylene, rehydrated through alcohol into PBS, and 
incubated for 10-20 min with 3% hydrogen peroxide (H2O2) in -20 ˚C to block endogenous 
peroxidase activity. Next, the sections were incubated for 1 h in PBS with 5% goat serum and 
0.3% Triton X100 at room temperature and then incubated overnight at room temperature with 
the same solution to which the primary antibody for MsrA (Abcam, cat# ab16803, diluted 1:100) 
was added. The following day, the slices were washed in PBS and then incubated with a 
biotinylated goat anti-rabbit IgG secondary antibody (Vector, cat # BA-1100 diluted1:400) for 3 
h at room temperature, then with a streptavidin Alexa 488 (Thermo Fisher, cat# A20000 
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diluted1:1000) for 1 h. The slide was then observed under a fluorescence microscope (Nikon, 




According to resource equation, the sample size was assigned to be eight mice (five 
knockouts and three wild-types). Our goal is to ensure obtaining an adequate power necessary to 
detect statistical significance in our research, as well, using the minimum number of animals to 
achieve efficiently the assigned objectives. The spiral ganglion neurons and fibrocytes numerical 
assessments for the two groups were calculated by determining the percentage of the present 
cells in the modular sections, where the basal and upper turns meet. We decided to select the 
arithmetic mean for the controls as the average cell counting number for normal hearing C57BL6 
mice, leading us to have almost 100 percent of spiral ganglion cellular density for MsrA wild- 
type mice. Then the statistical differences between the means of controls and subjects was 
measured using an unpaired Student’s t-test. 
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Histology 
 
We examined plastic-embedded cochlear cross-sections for evidence of histological 
changes in the mutant mice using a light microscope. It has been recently suggested that the 
spiral ligament fibrocytes, which interconnect with the basal cells of the stria vascularis via gap 
junctions, may be critical in maintaining cochlear homeostasis (Delprat et al., 2005). As shown 
in Figure 3 (adopted from Lieberman’s and Hirose’s study (2003), these types of cells are 
divided into four classes dependent upon their distinctive orientations and morphologies. Type I 
fibrocytes are situated near the stria vascularis, where the clusters travel to the spiral prominence. 
The bodies of these cells have widespread interdigitating bulging methods to make contact with 
adjacent cells through a group of membranes. The type II fibrocytes aid the function of type I 
fibrocytes and stria vascularis cells in recycling the potassium ions since these cells are a 
continuum for type I fibrocytes and the basal cells composed stria vascularis. Although both 
types I and II have the same physiological function, they are different in the cellular shape where 
is type II fibrocytes are less extended and have more fine processes than type I (Spicer & Schulte 
1991; Schulte & Steel, 1994). Type III fibrocytes are surrounded by bony otic and type I and II 
fibrocytes. Their shapes are variably flattened with honeycomb like processes. Lastly, the 
spindle-shaped type IV fibrocytes are located within the triangular area under the basilar crest. 
When compared to the control group, our results showed that fibrocytes in six-month-old 
knockout mice showed no difference in the population for type I, II, and III. The only exception 
was in fibrocyte type IV cells, which demonstrated a 60-70% loss in the knockout group across 
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the low frequencies (5-8 kHz) and high frequencies (16-26 kHz) regions, when compared to age- 




Figure 3: Schematic drawing of the cochlear duct shows the spatial organization and cellular 
shape of the four fibrocyte types in the lateral wall. Adapted from “Lateral wall histopathology 
and endocochlear potential in the noise damaged cochlea,” Hirose, K. and Liberman, M. C, 
2003, JARO - Journal of the Association for Research in Otolaryngology, 4(3), 339-352. 
 
 
While there is no loss of inner and outer hair cells (Figure 4D, E), six-month old MsrA 
knockout mice demonstrated a 20% loss of spiral ganglion neurons in the frequency region of 
16-26 kHz when compared to age-matched control mice (p<0.001) (Figure 4G, H, I). Loss of 
spiral ganglion neurons was not significantly different between wild type and MsrA knockout 
mice when counted in the frequency region of 5-8 kHz. 
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Figure 4: MsrA knockout mice show severe loss of type IV fibrocytes and Spiral ganglion 
neurons but do not show loss of hair cells. Loss of fibrocytes (A, B, and C) and spiral ganglion 
neurons (G, H and I) was seen as decreased density of cell population, although total hair cells 
(inner and outer hair cells) were not different from age matched wild type mice (D, E, and F). 
The data are expressed as the mean +/- S.E. Each point represents data from 3-5 mice for each 
group. Magnification 10X 
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Immunohistochemistry (IHC) 
 
Both the wild-type and knockout groups showed the same degree of staining, suggesting 
the MsrA antibody was not able to detect the difference in MsrA protein in the cochlea that is 
expected to exist between these two genotypic groups (Figure 5 C and D). To troubleshoot this, 
we tested the following potential factors that could contribute to negative or non-specific 
staining: (1) Antigen retrieval. We tried lowering the retrieval temperature from 97 ˚C to 70 ˚C, 
decreasing the duration of the retrieval process from 40 minutes down to 20, and changing from 
heating the tissues to adding enzymes (citrate buffer) to aid the lysis of unwanted proteins. (2) 
Tissue sections. Cryostat sections were used initially, then we changed to paraffin blocks to 
optimize conditions for antibodies to detect the MsrA protein. Despite several trials with these 
new conditions, the same results were observed. It is also possible that, due to the polyclonal 
nature of the MsrA antibody that was prepared using the full-length MsrA protein, it may 
recognize region(s) that are shared among Msr isoforms inside the cochlea. As the result, similar 
staining patterns are noticed in wild-type and MsrA knockout samples. 
To examine the possible presence in the MsrA knockout mice of other antigenic target 
proteins which are homologous to MsrA, we aligned the peptide sequence of MsrA with each of 
the MsrB isoforms individually. The results showed there is no resemblance between MsrA and 
MsrB2 or MsrB3. However, we found 14 common amino acid residues between MsrB1 and 
MsrA proteins (see Appendix A). If present at high levels, MsrB1 proteins could generate 
signals as detected by the MsrA antibody. 
Lastly, we confirmed the efficiency of the MsrA antibody in IHC by detecting MsrA in 
the brain, a tissue in which MsrA is highly expressed. Our results have shown that the MsrA 
antibody can detect MsrA protein in the brain of wild type mice, whereas no signals detected in 
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the MsrA knockout counterparts (Figure 5 A and B). This suggests that the low abundance of 
MsrA protein in the normal cochlea is most likely the reason for negative IHC staining, and this 
method is not sensitive one for studying the presence of MsrA proteins in the organ of Corti and 
spiral ganglion neurons. 







Figure 5: Intense MsrA immunoreactivity observed in the brain of wild-type mice (A), but not in 
the MsrA knockout mice (B), indicates the efficacy and specificity of the MsrA antibody. In the 
brain, strong label is observed in the cerebellum. However, nonspecific labeling was observed in 
the cochlear tissue (C and D), suggesting undetectable amount of MsrA protein within cochlear 
structures. Sections in A-D were immune-reacted together and images were taken at identical 





















































The main goal of this dissertation project was to further support our previous finding that 
the role of MsrA is to protect the cochlea from the damaging effects of noise and aging (Alqudah 
et al., ARO 2015 and 2016). The hypotheses were as follows:1) Reporting changes in the cell 
population of the MsrA mutant cochleas. The cellular densities for the studied structures are 
supposed to be less in MsrA knockout mice compared with wild-type controls. 2) Observing 
more detectable signals generated from MsrA antibody/antigens complexes in the normal MsrA 
cochleas than those present in the mutants. This discussion will offer explanations with details 
and observations to clarify the final conclusions. Potential future research will also be discussed, 
including an illustration of the possible human clinical application. 
Many studies have indicated MsrA as a major player in inhibiting neurological disorders 
like Alzheimer’s disease and Parkinson’s disease (Brot, Weissbach, Werth, & Weissbach, 1981; 
Gabbita, Aksenov, Lovell, & Markesbery, 1999). MsrA knockout mice showed impaired motor 
ability and abnormal behavior caused most likely by cerebellar dysfunction (Moskovitz et al., 
2001). Oxidative stress is a common process that occurs both in noise exposure and in aging. In 
the cochlea, oxidative stress can trigger accumulation of oxidized proteins, leading to damage of 
the sensory cells (hair cells) and auditory neurons, and exacerbating hearing loss. 
Methionine (Met) is an amino acid that is highly susceptible to oxidation, particularly 
under conditions of oxidative stress and aging (Levine & Luo, 2008; Stadtman et al., 2005; 
Stadtman, Moskovitz, & Levine, 2003; Stadtman, 2002;). Oxidation of Met to methionine 
sulfoxide (MetO) is reversible, and the reverse reaction is catalyzed by the methionine sulfoxide 
reductase system (Msr), comprising methionine S-sulfoxide reductase A (MsrA) and methionine 
R-sulfoxide reductase B (MsrB1-3). Consequently, the Msr system provides efficient protection 
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against oxidative stress by repairing oxidative damaged proteins, reinstating normal function to 
the repaired proteins, and reducing the accumulation of oxidized proteins in cells (Moskovitz, 
2007; Moskovitz et al., 1998; Moskovitz et al., 2001; Salmon et al., 2009). 
The combination of higher protein oxidation, induced by a constant oxidative stress, and 
compromised Msr system may induce more damage, leading to changes in protein structure and 
dysfunction of sulfoxidized proteins and cells. These resulting changes may eventually lead to 
permanent cell damage. 
A recent study reported MsrA expressing in the cells of organ of Corti, spiral ganglion 
neurons, and lateral wall (Maison et al., 2012). MsrA provides protection against age-related 
central nervous system (CNS) changes that are associated with neurodegenerative diseases 
(Moskovitz et al., 2002; Oien et al., 2008). MsrA also maintains proper function of neurons of the 
brain dopaminergic system (Liu et al, 2008; Oien et al, 2010; Oien et al, 2008; Ortiz, Oien, 
Moskovitz, & Johnson, 2011), a class of neurons that projects neurofibers within the cochlea and 
protect it from acoustic trauma (Gaborjan et al., 1999; Maison et al., 2012). Thus, MsrA was a 
strong candidate for studying the role of Msrs in protecting against AIHL and noise-induced 
hearing loss (NIHL). 
Prior to this study, we reported that MsrA mRNA levels of the cochlea increase during 
aging, while age-dependent expression of MsrB1 in MsrA knockout mice is compromised in 
comparison with wild-type controls. Furthermore, we showed that young MsrA knockout mice 
have normal neural hearing capabilities, which sharply worsen at older ages. Finally, we 
demonstrated that MsrA knockout mice exposed to noise show an increased vulnerability to 
acoustic trauma at both young and older ages; suggesting that MsrA mediates protection from 
noise also at older age (Alqudah et al., ARO 2015 and 2016). 
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Yet, information regarding histopathology of the cochlea in mice that lack MsrA is 
unknown. This study attempted to investigate the histological changes in normal and mutant 
MsrA mice following aging as a means of explaining the phenotype of hearing impairment. The 
results revealed that the six-month-old MsrA knockout mice had significant loss of spiral 
ganglion neurons mainly manifested at high frequencies and widespread loss of type IV fibrocyte 
cells in the lateral wall of the cochlea. 
We speculate that the loss of spiral ganglion neurons is the possible cause for the 
deterioration in the ABR responses in the mice that lack MsrA. This assumption stems from 
observing that the latency for ABR wave I in mice lacking MsrA, which originates from spiral 
ganglion neurons, is longer than in the wild-type mice (Melcher, Guinan, Knudson, & Kiang, 
1996). This means slower neural conduction velocity for processing the auditory signal delivered 
to the brain. Moreover, the sensory component of hearing loss present in MsrA mutant mice and 
characterized by abnormal DPOAE amplitudes and thresholds could be the result of loss of type 
IV fibrocytes. Previous studies reported that these fibrocytes are necessary to maintain the 
homeostasis of the endolymphatic fluid in scala media by regulating the flow of potassium ions 
in the endolymphatic fluid (Delprat et al., 2005). 
 
 
To examine the distribution of MsrA in the cochlea, we determined the cellular 
distribution of MsrA using immunohistochemistry in adult both wild-type and mutant MsrA 
mice. In this study, the protein expression was measured as the level of labeling intensity. While 
Intense MsrA immunoreactivity was observed in the brain of MsrA wild-type mice but not in the 
brain of knockout mice (Figure 5A and B), all cochlear samples from knockout and wild-type 
mice showed moderate to strong staining regardless of the genotype (Figure 5 C and D). 
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Therefore, we considered this result as non-specific staining. Various trials were conducted to 
improve the staining quality, yet, the same results were reported by two professional testers. The 
most likely interpretation to explain this non-specific staining is that the MsrA protein is not 
detectable in the mouse cochlea. Although our data revealed MsrA antibody labeling the 
supporting cells, spiral ligament, spiral limbus, Reissner's membrane and the spiral ganglion 
neurons (as shown in Kwan’s 2014 study) we were unable to differentiate the staining intensity 
between the wild-type and knockout mice and figure out any change in protein abundance inside 
the cochlea caused by mutation in MsrA gene. 
Details regarding tissue distribution differences between wild-type and knockout mice are 
still unclear since the IHC experiment was not powerful enough to detect the presence of MsrA 
in the cochlear tissue. Therefore, Western blot assay and in situ hybridization are planned for 
future experiments to identify the genotypic difference in protein expression and localization. 
MsrA mutant mice showed higher sensitivity to noise exposure than controls mice (Alqudah et 
al., ARO 2015); therefore, histological analysis of the cochlea of knockout mice exposed to noise would 
be helpful to investigate the molecular mechanism that are regulated by MsrA in protecting mice from 
noise damage. This will be accomplished by identifying the level of cellular damage caused by noise in 
mice which lack MsrA. 
Acquiring basic knowledge of the role of MsrA in hearing loss (using the MsrA knockout mouse 
as a tool) will greatly assist in understanding the age-dependent interactions between noise- and age- 
induced hearing-loss. Additionally, possible investigations into the specific role of MsrA protection from 
acoustic trauma may prompt a new line of studies to treat acoustic trauma through Msr-based therapy. 
Furthermore, these investigations may provide evidence for the possible roles of the Msr system in 
patients exhibiting age-related neurodegenerative pathologies of the central nervous system (CNS). 
28   
One of the limitations of this study is that the MsrA mutation is originally present in the 
C57BL/6 (B6) mouse strain, which is a poor model for the study of age-related hearing loss. The 
B6 mouse develops early age-related hearing loss due to a mutation in the gene for cadherin-23, 
and B6 mice are considered to have extreme variability in thresholds at high frequencies. 
Although B6 mice have normal hearing at younger ages (1-2 months), they have poor auditory 
responses at 12 months of age. We realize that the sound responses of this strain are so hard to be 
tracked with aging so that we restricted our study within four to six months of age. 
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Conclusion 
 
Our results indicated that MsrA is an essential factor in the encoding process of the 
protein that maintains the basic cellular structures in the cochlea, including spiral ganglion 
neurons and the type IV fibrocystes These structures have been reported as main contributors in 
processing the auditory signals in mammals. Moreover, MsrA mutant animals showed a 20% loss 
of spiral ganglion cells and a loss of 60% of fibrocystic class IV, which has been shown as a 
cause of sensorineural hearing loss in the high-frequency region (supported by 
electrophysiological tests). More investigation should be conducted to measure the MsrA protein 
level in wild-type and mutant mice in an effort to associate the observed phenotype, caused by 
the MsrA mutation, with microbiological modifications affecting the protein abundance inside 
the studied tissues. The ultimate goal for this study is to acquire basic knowledge of the role of 
MsrA in preventing hearing loss by using the MsrA knockout mouse model. This investigation 
will be useful to develop gene-based therapy that will replace, to a certain degree, the 
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Methionine Sulfoxide Reductase (Msr) System 
 
MsrA as a protective mechanism against neurodegeneration in the brain and the cochlea 
 
Prior studies have linked MsrA to protection against the onset of age-related 
neurodegenerative pathologies in the brain (Moskovitz et al., 2002; Oien et al., 2008) and the 
retina (Brennan & Kantorow, 2009; Sreekumar et al., 2011). This dissertation study tested the 
notion that MsrA might play a key role in the cochlea as well. 
Prior studies have shown that MsrA knockout mice have impaired dopaminergic signaling 
pathways (Ortiz et al, 2011; Salmon et al., 2009), suggesting a pivotal role for MsrA in protecting 
dopaminergic neurons from age-related neurodegeneration (Oien, et al, 2010). MsrA knockout 
mice exhibit neurodegenerative brain pathologies (Oien, 2008) and malfunction of brain 
dopaminergic neurons, probably due to the observed loss of dopamine receptor 2 (D2DR) 
activity (Liu et al., 2008; Oien et al., 2010; Oien et al., 2008; Ortiz et al, 2011). Studies published 
in the last two decades show that the cochlea contains dopaminergic innervation and regulates 
cochlear responses to sound. Felix and Ehrenberger (1992) provided evidence that the firing rate 
of afferent fibers contacting the inner hair cells is suppressed following application of dopamine 
and that dopamine action is mediated by dopamine receptors activation. Inoue et al. (2006) 
demonstrated the expression of several dopamine receptors in the cochlear neurons beneath the 
inner hair cell region, and Darrow, Simons, Dodds, and Liberman (2006) suggested that 
dopaminergic neurons from the olivocochlear nuclei extend towards beneath the inner hair cells 
to form dopaminergic endings. However, only recently, Maison et al. (2012) confirmed that mice 
lacking dopamine receptors exhibit exacerbated damage from acoustic trauma, suggesting that 
dopaminergic innervation might act to minimize glutamate-induced excitotoxicity resulting from 
acoustic trauma (Maison et al., 2012; Ruel et al., 2001) 
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Mechanisms of Msr-mediated protection in the inner ear 
 
The possible role of MsrB1 in hearing loss has not yet been investigated due to the lack 
of relevant mouse models and insufficient knowledge about the possible mutations of this gene 
in humans. However, Kwon et al. (2014) reported the expression of MsrB1 in the inner, outer 
hair cells of the organ of Corti, and in the spiral ganglion, suggesting a possible role of MsrB1 in 
protection from cochlear oxidative stress. Another report indicated that MsrB1 is expressed in 
the liver, which declines with age (Moskovitz et al., 2002). In our previous study, we observe 
that MsrB1 expression in young MsrA knockout mice is also compromised (see Appendix B), 
suggesting that MsrB1 might be likely regulated by MsrA in an age-dependent fashion and/or 
cochlea protection might be mediated by MsrA or MsrB1 or both (Alqudah et al., ARO 2015- 
2015). 
Possible role of Msr-mediated protection from acoustic trauma 
 
The published literature regarding acoustic injury is in agreement with the general 
observation that a narrow band (8-16 kHz) of sound exposure for 2 h at a sound pressure level 
equal to or less than 100 dB triggers the mechanical stereocilia damage but not sensory cell loss 
(Karadaghy et al.,1997). Furthermore, the protective process from the oxidative stress generated 
by this type of noise is still ambiguous and need further investigation. 
MsrB3 has been linked to deafness in humans and mice, suggesting a crucial role of 
MsrB3 in the development or functioning of the inner ear. Ahmad and his colleagues (2011) 
reported that MsrB3 is present at the base of hair cell stereocilia and controls the maturation, thus 
suggesting a role of MsrB3 in the maintenance of stereocilia structure. Consistent with the 
location of MsrB3 and with the generation of stereocilia damage following acoustic trauma, 
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MsrB3 could elicit protection against generation of acoustic injury by repairing R-MetO 
containing proteins in stereocilia. 
Immunohistochemistry of Msr 
 
Previous studies indicated that the expression profiles of the Msr genes do not follow 
systematic pattern and vary from one part of the body to another (Kim & Gladshev, 2004; 
Marchetti et al., 2005; Taungjaruwinai, Bhawan, Keady, & Thiele, 2009). These variations in the 
expression of Msr genes were observed even in the cellular level, where MsrA and MsrBs are 
distributed unequally in different subcellular structures. According to Kim and Gladshev (2004), 
MsrA is expressed in nucleus, cytosol and mitochondria while MsrB1 in cytosol and nucleus, 
MsrB2 in mitochondria, and MsrB3 in endoplasmic reticulum or mitochondria. Among various 
tissues and organs, MsrA is mostly expressed in the kidney, cerebellum, and liver; MsrB1 is 
highly expressed in liver, pancreas, and leukocytes; MsrB2 is predominantly in the heart, liver, 
and skeletal muscle; and MsrB3 largely in the bladder, aorta, heart, and skeletal muscle. 
In some areas of human body, Msr family members were detected in different 
proportions within the same system, for example, in the skin. Taungjaruwinai, Bhawan, Keady, 
and Thiele (2009) reported in his study that MsrA strongly expresses in all keratinocytes, except 
the stratum corneum. Moreover, MsrA is detectable in melanocytes, sebaceous gland, eccrine 
gland, hair follicles, and blood vessels. Although the MsrB is divided to three subsets, it is 
common to see the expressions of all MsrBs at the same spot, but in a compressed level for each 
one of them. The results of the study revealed that MsrB1 and MsrB3 expression was detected in 
blood vessels, while MsrB2 was observed within melanocytes. In the ocular system, MsrB1 and 
MsrB3 are weakly expressed in both the epithelium and fiber cells. Whereas, MsrA normally is 
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more expressed in the epithelium than fiber cells, and MsrB2 expression was higher in the fiber 
cells than in epithelium (Marchetti et al., 2005). 
The presence and distribution of Msr family members in the hearing system has been 
studied by one group of researchers so far (Kwon et al., 2014). Their findings indicated that these 
genes have been defined in both cochlear and vestibular organs of inner ear. Interestingly, as in 
skin and ocular systems, each Msr is limited to specific cochlear structures and different Msr 
genes are expressed at various levels. Moreover, they showed that MsrA was highly expressed in 
the supporting cells, spiral ligament, spiral lamina, and Reissner’s membrane, with the lowest 
expression level in the spiral ganglion cells. They also suggested that MsrB1 is expressed largely 
in hair cells and the spiral ganglion region, whereas MsrB2 is likely expressed in the spiral 
ganglion, tectorial membrane and stria vascularis, and none in the organ of Corti. The  
researchers verified that MsrB3 protein is present in rod-like patterns at the base of each 
stereocilium but poorly expressed in hair cell bodies. 
To further advance the understanding about the location and function of Msr genes in the 
auditory system, Kwon et al. also analyzed the vestibular tissues. In addition, they documented 
that MsrA, MsrB1 and MsrB2 are also detectable in varied ratios. Their research indicated that 
MsrA and MsrB1 are strongly expressed in almost all the parts of vestibule: the sensory and 
neural cells of the crista ampullaris, utricle, and saccule, while MsrB2 is not expressed in the hair 
cell of the vestibule and scattered in the vestibular ganglion neurons. Similar localization of 
MsrB3 protein at the base of stereocilia was also observed in vestibular hair cells. 
Histopathology of age related hearing loss 
 
In the mouse model, the age-related hearing loss causes histological changes 
accompanied with alternations in the physiological function of hearing system. Early studies 
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have been focused on the integrity of two types of cell populations, hair cells and spiral ganglion 
neurons, within the scala media structures to explain the pathophysiological modifications 
associated with ARHL. In the C57BL/6J mouse, ARHL starts initially in the high frequency 
region at about 3 to 6 months of age and then continues to include all frequencies by 15 months 
(Henry,1983; Willot, Parham, & Hunter, 1991). White and her colleagues (2000) documented 
the pattern and the sequence of degeneration in the hair cells and spiral ganglion neurons as the 
C57BL/6J mice are aging. They showed that, by age 8 months, the C57BL/6J mouse has only 
4% of the outer hair cells remaining. At age of 18 months, massive loss of inner hair cells was 
reported in these mice and only 29% of the cells were present. By 26 months of age, more than 
80% of the OHCs were absent across the whole cochlea while IHC losses were approximately 
100% close to the base of the cochlea and about 20% in the apical turn. Regarding the peripheral 
neural component of the hearing system, there was a substantial decline with age in spiral 
ganglion cell density, which was strongly correlated with surviving inner hair cells previously 
defined. In general, age-related progressive degeneration of spiral ganglion cells was worsening 
from distal location in the osseous spiral lamina (near the organ of Corti) than at a proximal 
location (near the spiral ganglion). 
Liberman and Hequembourg (2001) investigated the role of structures such as spiral 
lamina, stria vascularis, and spiral ligament in the histopathology of aging in mice. They 
confirmed conclusions from previous studies that found hair cell loss follows a basal to apex 
gradient. They also observed that the spiral ganglion neurons underwent degeneration as a result 
of the aging process. This conclusion was based on an observation that spiral ganglion damage is 
steadily increasing from apex to the midcochlear region in aged ears, which is opposing the 
direction of gradual inner hair cells death.  In addition, this study also showed that ARHL is 
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targeted through fibrocyte type IV that are located in a triangular region of spiral ligament just 
below the point of insertion of the basilar membrane (Henson & Henson, 1988). Heumen, 
Claxton, and Pickles (2000) suggested that this class of fibrocytes is essential to maintaining the 
hemostasis of scala media, based on the fact that these fibrocytes have a large expression of 
tyrosin kinase receptors that are highly selective receptors to the ions entering the cochlea. The 
type IV fibrocyte loss started earlier than that for the loss of hair cells, specifically by the age of 
3 months, and extended further beyond the OHC loss region. Thus, the presence of early and 
severe degeneration in the fibrocytes predicts the decline in the hair cell population during aging 
process. This study provides the evidence that defects in the spiral ligament, especially at the 
fibrocytes type IV, might initiate the neural degeneration and other forms of sensory hearing 
loss. 
Age-dependent sensitivity to noise 
 
It is known that ears exhibiting noise damage age differently than those without damage 
(Kujawa & Liberman, 2006), and that noise exposure is more detrimental at younger ages than 
later (Kujawa & Liberman, 2006). These observations suggest that there is a protective 
mechanism against damage from exposure to noise in the cochlea that is also tightly regulated 
with age. Ohlemiller, Wright and Heidbreder (2000), and then Kujawa and Liberman (2006) 
provided direct evidence that cochlear sensitivity to noise is an age-dependent phenomenon. 
Notably, these researchers have shown that young mice are more sensitive to noise 
exposure/damage than older mice and that this sensitivity in younger mice is followed by a sharp 
reduction in sensitivity in adulthood (between 8 and 16 weeks of age). Kujawa and Liberman 
(2006) suggested that metabolic changes happening within the cochlea might explain this 
phenomenon.  This notion is supported by the observation that attenuation of the middle ear 
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sound transmission has little influence on sensitivity to noise between 8 and 16 weeks 
(Rosowski, Brinsko, Tempel, & Kujawa, 2003). 
Degeneration of the cochlear synaptic terminals 
 
Literature is in agreement with the observation that the most distinct pathological site for 
both noise-induced hearing loss and age-related hearing loss are the spiral ganglion neuron 
terminals that contact the inner hair cells (IHC) (Lin, Furman, Kujawa, & Liberman,2011; 
Liberman & Kujawa, 2009; Liberman & Kujawa, 2014; Perez & Bao, 2011; Sergeyenko et al., 
2013). In aging animals, loss of afferent synapses of the IHCs is progressive throughout life and 
across the whole cochlea (Perez & Bao, 2011). However, after noise, loss of synapses during 
aging is severe and especially in the frequency region where noise exposure generated high 
thresholds (Lin et al., 2011; Liberman & Kujawa, 2009; Liberman & Kujawa, 2014; Sergeyenko 
et al., 2013). The mechanism of damage of afferent synapses is based on the observation that 
following noise exposure IHC synapses swell and rupture within hours after exposure (Pujol & 
Puel 1999; Wang et al., 2002). Synaptic swelling is the most likely result of excitotoxicity from a 
large release of glutamate from the IHC during the noise exposure (Kujawa & Liberman 2009). 
Numerous studies have suggested that degeneration of synapses target a specific group of 
fibers in the cochlea that have a low spontaneous discharge firing rate 
(Buran et al., 2010; Furman et.al, 2013; Schmiedt et al.,1996; Sergeyenko et al., 2013). For 
instance, cochlear neurons exhibit a range of spontaneous discharge firing rates: from low 
spontaneous discharge rate neurons (activated when in presence of high level of sound) to high 
spontaneous discharge rate neurons (activated when in presence of a low level of sound) 
(Liberman & Dodds 1984). There is no evidence as to why neurons with low spontaneous 
discharge firing rates are more vulnerable to noise exposure than those with high spontaneous 
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discharge rates. However, it is possible that low spontaneous discharge firing rates fibers are 
more sensitive to overload of Ca2+ (which its cellular concentration increase during profuse 
release of neurotransmitter glutamate), triggering cellular excitotoxicity and cell death. 
In order to answer this and other questions relating to noise effects, researchers need to 
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Graphical display of BLASTP results of protein sequence alignment of 
MsrB1 with MsrA. The black line represents a mathematical score of weak 
similarity between MsrA and MsrB1 polypeptides.  Sequence similarities 
are indicated by scores associated with various colors (left to right: weak to 
strong). 






























The BLASTP result of the strongest alignment between MsrB1 and 
MsrA, showing 8 identical and 5 chemically similar (+) residues 
spanning a stretch of 25 residues, which corresponds to 24% identity. 
The definition of nomenclatures can be found at the following website: 
https://blast.ncbi.nlm.nih.gov/Blast.cgi. 































Negative BLASTP search result of MsrB2- MsrA alignment. 



























































































MsrA mRNA post-birth and in adults. Quantitative RT-PCR of cochleae (organ of Corti and 
spiral ganglia) indicated MsrA mRNA levels are high right after birth but decrease rapidly 
thereafter (around 12 days), reaching the lowest level at 60 days (a) (p<0.0001 compared to 
6- days post birth using the unpaired Student’s t-test). Aging increases cochlear Msrs mRNA 
levels in the adult by 6 months of age (b and c) (p<0.0001 compared to 1month using the 
unpaired Student’s t-test); except for MsrB2, which decreases by half (b)(p<0.0001). Msrs 
mRNA changes in MsrA knockout mice. Quantitative RT-PCR of cochleae indicated MsrB1 
mRNA levels did not increase at 6 months of age (p>0.05 compared to 1-month post birth using 
the unpaired Student’s t-test), whereas MsrB3 increases (p<0.0001), suggesting that the lack of 
MsrA, and possibly aging, might regulate MsrB1 in the cochlea but not MsrB3. The mean ± S.E. 
are plotted. Each point in a-c represents data from 4 and 5 mice, respectively 
 
 
 
 
 
 
  
